---
title: "诺瓦瓦克斯医药 (NVAX.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/NVAX.US/norm.md"
symbol: "NVAX.US"
name: "诺瓦瓦克斯医药"
parent: "https://longbridge.com/zh-CN/quote/NVAX.US.md"
datetime: "2026-05-21T08:49:34.615Z"
locales:
  - [en](https://longbridge.com/en/quote/NVAX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NVAX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NVAX.US/norm.md)
---

# 诺瓦瓦克斯医药 (NVAX.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0581 | 0.1078 | -1.25 | 0.6159 | 2.93 |
| ROE | 27.86% | -49.30% | 1359.99% | -2241.21% | -593.18% |
| 营业收入 | 139.51M | 147.14M | 70.44M | 239.24M | 666.65M |
| 净利润 | -9.49M | 17.53M | -202.38M | 106.51M | 518.65M |
| 营业利润 | -10.03M | 20.94M | -79.38M | 105.67M | 516.01M |
| 毛利率 | 19.42% | 7.60% | -47.21% | 66.44% | 86.51% |
| 净利率 | -6.80% | 11.91% | -287.29% | 44.52% | 77.80% |
| 利润含金量 | - | -53.04% | -73.63% | -82.90% | -278.17% |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 1.04B | 1.18B | 1.18B | 1.34B | 1.29B |
| 权益乘数 | -7.21 | -9.21 | -7.53 | 35.52 | -17.09 |
| 每股净资产 | -0.8804 | -0.7858 | -0.9643 | 0.2320 | -0.4671 |
| 资产周转率 | 0.5105 | 0.8210 | 0.7362 | 0.6838 | 0.9484 |
| 现金及短投 | 790.33M | 735.08M | 762.89M | 612.30M | 731.48M |
| 存货与应收 | 11.46M | 11.54M | 13.51M | 10.24M | 10.26M |
| 长期投资 | 63.51M | 67.70M | 72.99M | 282.69M | 291.03M |
| 净债务 | -495.27M | -457.04M | -511.75M | -383.81M | -502.82M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -32.42M | -39.48M | 107.80M | -127.46M | -185.50M |
| 投资现金流 | -28.36M | 20.48M | -136.53M | 111.10M | -73.32M |
| 融资现金流 | 37.67M | -6.60M | 42.44M | -1.04M | -7.06M |
| 自由现金流 | 78.74M | 15.16M | 100.26M | -121.47M | -311.81M |
| 现金流充裕率 | -1754.49% | -472.75% | 3592.27% | -14838.42% | -4886.78% |
| 举债与偿债 | 46.41M | 0.0000 | 42.61M | - | - |
| 资本支出 | -1.27M | -2.08M | -2.02M | -247000.00 | -1.59M |